Deutsche Bank’s Jade Biosciences, Inc. Common Stock JBIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $256K | Buy |
25,614
+25,475
| +18,327% | +$254K | ﹤0.01% | 2819 |
|
|
2025
Q1 | $12.2K | Buy |
139
+118
| +562% | +$10.4K | ﹤0.01% | 3456 |
|
|
2024
Q4 | $1.91K | Buy |
+21
| New | +$1.91K | ﹤0.01% | 3506 |
|
|
2024
Q3 | – | Sell |
-906
| Closed | -$52.7K | – | 3519 |
|
|
2024
Q2 | $52.7K | Buy |
906
+769
| +561% | +$44.7K | ﹤0.01% | 3278 |
|
|
2024
Q1 | $141K | Sell |
137
-5
| -4% | -$5.16K | ﹤0.01% | 2970 |
|
|
2023
Q4 | $113K | Hold |
142
| – | – | ﹤0.01% | 3123 |
|
|
2023
Q3 | $67.6K | Hold |
142
| – | – | ﹤0.01% | 3304 |
|
|
2023
Q2 | $85.5K | Sell |
142
-19
| -12% | -$11.4K | ﹤0.01% | 3329 |
|
|
2023
Q1 | $114K | Buy |
161
+53
| +49% | +$37.4K | ﹤0.01% | 3265 |
|
|
2022
Q4 | $111K | Buy |
108
+2
| +2% | +$2.05K | ﹤0.01% | 3270 |
|
|
2022
Q3 | $62K | Sell |
106
-18
| -15% | -$10.5K | ﹤0.01% | 3496 |
|
|
2022
Q2 | $68K | Sell |
124
-32
| -21% | -$17.5K | ﹤0.01% | 3631 |
|
|
2022
Q1 | $100K | Sell |
156
-18
| -10% | -$11.5K | ﹤0.01% | 3542 |
|
|
2021
Q4 | $72K | Buy |
174
+8
| +5% | +$3.31K | ﹤0.01% | 3745 |
|
|
2021
Q3 | $122K | Buy |
+166
| New | +$122K | ﹤0.01% | 3759 |
|